Clinical Trials Directory

Trials / Unknown

UnknownNCT03825276

Effect of Mango on Gut Microbiota and Metabolic Health

Metabolic Adaptations and Role of Nutritionally-Mediated Gut Microbiota Changes Following Mango Consumption in Overweight Men and Women : The MANGO Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Mango is rich in bioactive compounds such as dietary polyphenols and carotenoids, which may explain its beneficial effect on health. Polyphenols accumulate in the gut where they can positively modulate the microbiota. As gut microbiota may have a strong influence on cardiometabolic health, we hypothesize that mango consumption improves metabolic profile in overweight or obese individuals through beneficial changes in gut microbiota. The study of metagenomics, transcriptomics and metabolomics will be used to validate this hypothesis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMango consumptionDaily consumption of 280 g of frozen mangos during 8 weeks. The daily dose in equivalent to a 2-cups serving.

Timeline

Start date
2019-01-15
Primary completion
2019-12-20
Completion
2022-12-01
First posted
2019-01-31
Last updated
2021-07-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03825276. Inclusion in this directory is not an endorsement.